Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aveanna Healthcare Holdings (AVAH) Shares Outstanding (2020 - 2026)

Aveanna Healthcare Holdings (AVAH) has disclosed Shares Outstanding for 6 consecutive years, with $208.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding rose 8.12% year-over-year to $208.9 million, compared with a TTM value of $208.9 million through Sep 2025, up 8.12%, and an annual FY2024 reading of $193.2 million, up 1.31% over the prior year.
  • Shares Outstanding was $208.9 million for Q3 2025 at Aveanna Healthcare Holdings, roughly flat from $208.3 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $208.9 million in Q3 2025 and bottomed at $141.9 million in Q2 2021.
  • Average Shares Outstanding over 5 years is $188.7 million, with a median of $190.4 million recorded in 2023.
  • The sharpest move saw Shares Outstanding changed 0.0% in 2021, then surged 30.16% in 2022.
  • Year by year, Shares Outstanding stood at $184.2 million in 2021, then rose by 2.55% to $188.9 million in 2022, then rose by 0.99% to $190.7 million in 2023, then rose by 1.31% to $193.2 million in 2024, then grew by 8.12% to $208.9 million in 2025.
  • Business Quant data shows Shares Outstanding for AVAH at $208.9 million in Q3 2025, $208.3 million in Q2 2025, and $195.1 million in Q1 2025.